The global Peripherally Inserted Central Catheter (PICC Line) market was valued at US$ 565 million in 2024 and is anticipated to reach US$ 788 million by 2031, witnessing a CAGR of 4.7% during the forecast period 2025-2031.
The peripherally inserted central catheter (PICC line) market is growing steadily as healthcare providers increasingly adopt these devices for long-term intravenous (IV) therapy. PICC lines are widely used in patients requiring extended medication, chemotherapy, nutrition, or antibiotic treatments. With the rising prevalence of chronic diseases, cancer therapies, and home healthcare services, the demand for PICC lines is expanding globally.
Read Full Research Report: https://www.qyresearch.in/report-details/8916324/Global-Peripherally-Inserted-Central-Catheter-(PICC-Line)-Market-Insights
What is a Peripherally Inserted Central Catheter (PICC Line)?
A PICC line is a thin, flexible tube inserted through a vein in the arm and advanced toward a large central vein near the heart. It provides reliable access for long-term administration of IV drugs, fluids, or nutrients.
Key advantages include:
- Reduced need for repeated needle sticks
- Lower risk of infection compared to other central venous catheters
- Suitable for both hospital and home-based care
- Cost-effective option for long-duration therapies
PICC lines are commonly used for patients undergoing cancer treatment, long-term antibiotic therapy, and total parenteral nutrition (TPN).
Market Drivers
Growing Prevalence of Chronic Diseases
Rising cases of cancer, cardiovascular diseases, and infectious conditions are driving demand for long-term IV access devices like PICC lines.
Expansion of Chemotherapy and Oncology Treatments
Cancer patients undergoing multiple chemotherapy cycles benefit from PICC lines, which provide safe and continuous venous access.
Growth of Home Healthcare Services
PICC lines are increasingly used in home healthcare settings for patients requiring ongoing IV treatment, reducing hospital stays and costs.
Technological Advancements in Catheter Materials
Innovations in biocompatible materials, antimicrobial coatings, and ultrasound-guided insertion techniques are improving safety and outcomes.
Market Segmentation
The PICC line market can be segmented by:
- Product Type: Single-lumen, double-lumen, multi-lumen catheters
- Material: Polyurethane, silicone, antimicrobial-coated catheters
- Application: Oncology, parenteral nutrition, antibiotics, cardiovascular therapies
- End User: Hospitals, ambulatory surgical centers, home healthcare, specialty clinics
Single-lumen catheters dominate the market due to their wide usage in simple IV therapies, while multi-lumen devices are gaining traction in complex treatments requiring simultaneous infusions.
Regional Insights
- North America leads the market, with the U.S. showing strong adoption due to advanced healthcare infrastructure, high cancer prevalence, and robust home healthcare systems.
- Europe follows, with Germany, France, and the UK driving demand through rising chronic disease burden and supportive reimbursement policies.
- Asia-Pacific is the fastest-growing region, with countries like China, India, and Japan increasing healthcare investments, expanding hospital facilities, and adopting PICC lines in oncology and infectious disease treatments.
- Latin America is emerging, particularly in Brazil and Mexico, where healthcare modernization is boosting market growth.
- Middle East & Africa present opportunities as investments in healthcare infrastructure and chronic disease management expand.
Competitive Landscape
The PICC line market is moderately consolidated, with leading players focusing on product innovation and partnerships with healthcare facilities. Major companies include:
- Becton, Dickinson and Company (BD)
- Teleflex Incorporated
- Cook Medical
- AngioDynamics, Inc.
- Medtronic Plc
- Vygon SA
- Smiths Medical
These players are investing in antimicrobial catheters, user-friendly insertion kits, and training programs for healthcare professionals.
Challenges and Opportunities Challenges:
- Risk of complications such as thrombosis, infections, and catheter occlusion
- Need for skilled professionals for insertion and maintenance
- Variations in reimbursement policies across regions
Opportunities:
- Growing demand for antimicrobial-coated PICC lines to reduce infection rates
- Expansion of home infusion therapy in developed and emerging markets
- Development of ultrasound-guided and navigation-assisted insertion technologies
- Rising healthcare expenditure in Asia-Pacific and Latin America
Future Outlook
The PICC line market is expected to grow steadily as demand for long-term intravenous therapies increases worldwide. Future trends will include:
- Wider adoption of antimicrobial and biocompatible catheter technologies
- Integration of smart monitoring systems for early detection of complications
- Growing preference for home-based treatment options
- Expansion of training programs to improve insertion accuracy and patient safety
As chronic diseases and long-term therapies continue to rise, PICC lines will play an essential role in delivering safe, effective, and cost-efficient intravenous care.
QY Research established in 2007, focus on custom research, management consulting, IPO consulting, industry chain research, data base and seminar services. The company owned a large basic data base (such as National Bureau of statistics database, Customs import and export database, Industry Association Database etc), expert's resources (included energy automotive chemical medical ICT consumer goods etc.
Contact Us:
QY Research, INC.
315 Work Avenue, Raheja Woods,
Survey No. 222/1, Plot No. 25, 6th Floor,
Kayani Nagar, Yervada, Pune 411006, Maharashtra
Tel: +91-8669986909
Emails - [email protected]
